Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.68

-2.4%

Dec 12 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who started this subject	7/3/2001 7:30:04 PM
From: limit	of 52153

VRTX Expected Upcoming Events 3Q:01 Complete ABSC acquisition 2H:01 Initiate Phase III trial for VX-175 for the treatment of hepatitis C virus 2H:01 Results Phase II trial for VX-740 in the treatment of rheumatoid arthritis 2H:01 Results Phase II trial for VX-745 in the treatment of rheumatoid arthritis 2H:01 Results from Phase II trial for Timcodor and elucidation of development strategy 2H:01 Elucidation of development strategy for MDR program 2H:01 Complete Phase I trials for VX-148, the second generation IMPDH inhibitor 2H:01 Initiate Phase II trials for VX-148 in the treatment of autoimmune diseases 2H:01 Complete Phase III trials for VX-175 in the treatment of HIV

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next